Until now, it has been difficult to maintain retinal ganglion cells deep inside organoids over extended periods. The supply ...
India Today on MSN
Why everyone is swapping retinol for retinal
Has it ever happened that your 'cooler' sibling stole all your limelight? Well, that's exactly what retinal is doing to ...
Two of Opus's seven gene therapy assets are in clinical trials, with additional programs expected to enter the clinic.
Find out how scientists are maximizing retinal organoid effectiveness to sustain critical retinal ganglion cells.
Live Science on MSN
These genes were thought to lead to blindness 100% of the time. They don't.
New research finds that retinal diseases thought to map one-to-one to genetic mutations are more complicated than that.
Sanofi may rebid for Ocular Therapeutix, Inc. to boost retinal therapeutics ahead of Dupixent patent expiry. Click for more ...
News-Medical.Net on MSN
Engineered vessels boost retinal organoid function, enabling advanced disease modeling
Until now, it has been difficult to maintain retinal ganglion cells deep inside organoids over extended periods. The supply ...
RetinalGenix is developing a portfolio of non‑invasive imaging solutions, including a portable Retinal Imaging Screening Device and the RetinalCam remote monitoring system, designed for use without ...
After unsheathing just a few months ago, Ollin Biosciences’ next-gen bispecific antibody cleared more disease faster than ...
About the LUCE-1 Trial LUCE-1 is a Phase 1/2 multicenter, open-label, dose escalation study investigating safety, tolerability and preliminary efficacy of 3 dose levels of dual AAV8.MYO7A (AAVB-081) ...
The blood-brain and blood-retinal barriers are protective systems that prevent harmful substances from entering the brain and ...
The addition of RACI reflects AllyGPO and BioCareSD's continued growth in community retina, as practices seek support in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback